Hansa Biopharma has reported a 135% increase in fourth-quarter revenue [...]

BOOST Pharma has appointed Hans Schambye as its new chief [...]

Endometriosis is typically treated as a single condition, yet patients [...]

Newron has expanded the intellectual property protection for its lead [...]

Symbiosis Pharmaceutical Services has completed its first commercial-scale manufacturing run [...]

UCB has reported positive findings from the Gemz phase 3 [...]

Phase 3 data for GSK’s depemokimab appear to support the [...]

InflaRx has reported its Q2 2025 results and provided updates [...]

Cybin’s lead psychedelic-based candidate CYB003, designed as an adjunctive treatment [...]

Landmark debt deal enables commercial readiness for ITM-11, supports pipeline [...]